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Introduction
During last decades C. difficile infection (CDI) has
emerged as a most frequent health-care associated cause
of morbidity and mortality in developed world. In Europe
about 40,000 patients die each year of CDI, in Poland
rapid increase of CDI rates has been observed, reaching
appr. 11,500 hospitalized cases in 2013.
Objectives
In mild cases metronidazole is the first-line therapy,
with effectiveness of 66%. In severe cases vancomycin is
used with cure rate about 78%. Novel therapy with
fidaxomicin shows similar clinical cure rates to vanco-
mycin with lower recurrence rates. Alternative method,
fecal microbiota transplantation (FMT) for CDI treat-
ment has been reported since 1958 with worldwide
response rates of 83-94% as claimed by reviews.
Methods
We perform the first prospective, non-randomized, multi-
center, observational study to estimate the effectiveness of
FMT in the treatment of recurrent CDI, including 2 hospi-
tals and one ambulatory center in Poland. The procedure
has been proposed for patients with recurrent C. difficile
infection that have failed to respond to antimicrobial ther-
apy. All donors, related or unrelated, after obtaining
informed consent, have been screened for enteric bacterial
pathogens, viruses and parasites according to published
guidelines.
Results
Donor stool after dilution with 0,9% saline has been fil-
tered and resulting suspension has been infused via a
nasogastric tube. All patients have signed informed
consent according to the written procedure. From 2013
to 2014, in total, 62 patients aged 24-90 years received
FMT with resolution of clinical symptoms of 88,7%.
Among 55 successfully treated patients, in 76,5% cases
recovery has been observed after first FMT procedure,
in 14,5% after the second, and in 9% after the third one.
There were no statistically significant differences
between the cure rates of related and unrelated donor
or fresh and frozen samples. There were no severe
adverse events observed. Mild diarrhoea, temporary con-
stipation, nausea, flatulence and abdominal pain were
most frequently reported side effects.
Conclusion
Although majority of physicians currently consider FMT
as an experimental therapy, we showed that FMT is
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